This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

James F. Bale, JR, MD
Division of Pediatric Neurology

Robert W. Allen, JR, MD; Joan Hulme, MD; Michael L. Wyman, MD
Intermountain Newborn Intensive Care Center University of Utah Medical Center Salt Lake City, UT 84132

Arch Neurol. 1981;38(4):263-264.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The review on the pregnant epileptic by Montouris et al (ARCHIVES 1979;36:601-603) succinctly summarized several important fetal and neonatal complications of maternal anticonvulsant therapy. Although the problem of anticonvulsant-related teratogenesis has received considerable attention in recent years,^1-3 other complications, particularly hemorrhagic disease, can pose more immediate and potentially life-threatening problems in the neonatal period.

We recently cared for a term newborn infant in whom an intracranial hemorrhage developed as a complication of anticonvulsant-induced hemorrhagic disease. The infant had no external evidence of hemorrhage, and Computed tomographic Scan showing right frontal intraparenchymal hemorrhage (arrow). the neurologic symptoms the infant experienced were initially attributed to barbiturate withdrawal. However, a head computed tomographic (CT) scan disclosed an intraparenchymal cerebral hematoma.

Report of a Case.—

A 2,900-g male infant was born after a 38-week gestation to a 33-year-old woman. Her six previous pregnancies had resulted in two living children and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?